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Abstract
Uterus transplantation is an experimental infertility treatment for women with uterine factor
infertility. During donor uterus retrieval and subsequent storage, ischemia and other stress-
ors are likely to occur, resulting in the delayed restoration of organ function and increased
graft rejection. The uterus expresses connexin-based hemichannels, the opening of which
can promote ischemic cell death, as well as gap junctions that may expand cell death by
bystander signaling. We investigated if connexin channel inhibition with connexin channel
inhibitor Gap27 could protect the uterus against cell death during the storage period. The
study involved 9 female patients undergoing gender-change surgery. Before uterus removal,
it was exposed to in situ warm ischemia with or without reperfusion. Uterus biopsies were
taken before, during, and after ischemia, with or without reperfusion, and were subsequently
stored under cold (4ᵒC) or warm (37ᵒC) conditions. TUNEL cell death assay was done at
various time points along the combined in vivo/ex vivo experimental timeline. We found that
Gap27 protected against storage-related cell death under cold but not warm conditions
when the uterus had experienced in situ ischemia/reperfusion. For in situ brief ischemia with-
out reperfusion, Gap27 reduction of cell death was delayed and significantly less, suggesting
that protection critically depends on processes initiated when the organ was still in the donor.
Thus, the inclusion of the connexin channel inhibitor Gap27 during cold storage protects the
uterus against cell death, and the degree of protection depends on the history of exposure to
warm ischemia. Gap27 protection may be indicated for uteri from deceased donors, in which
ischemia is likely because life-saving organs have retrieval priority.
Introduction
Uterus transplantation is an experimental infertility treatment option for women with a dys-
functional or absent uterus, also known as absolute uterine factor infertility. After extensive
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research on several animal species [1], Brännström’s team described the first human delivery
after uterus transplantation from a living donor in 2014, and since then, more live births were
recorded [2–6]. The retrieval of the uterus from a living donor has the advantage that the
organ can be examined for uterine and cervical pathologies before transplantation, however,
the donor patient faces surgical and postoperative risks. Deceased and cadaveric donors may
bring additional difficulties because the timing of the procedure is dependent on the availabil-
ity of the suitable donor, and on the organ retrieval priority from a multi-organ donor. The
first human uterus transplantation from a multi-organ brain-dead donor was performed by
Özkan, where the uterus was the first organ to be retrieved, creating the best conditions to pre-
vent cell injury related to warm ischemia [7]. The first live births after uterus transplantation
from multi-organ deceased donors were described recently in Brazil and in the US [6, 8]. The
success of uterus transplantation may be further increased by applying treatments that mini-
mize ischemia-reperfusion (further abbreviated to I/R) injury [1]. Long ischemic exposures
and reperfusion injury are indeed associated with impaired post-transplantation perfusion,
delayed graft function, and increased frequency of acute or chronic rejection. During the
transplantation process, both cold ischemia (in the period between flushing and the start of
anastomosis surgery), as well as warm ischemia (during anastomosis surgery), can occur [9],
which may lead to cell injury followed by apoptotic or necrotic cell death. Once perfusion is
re-established, reperfusion injury may aggravate things [10]. Ischemia, as well as I/R injury,
are two conditions well known to involve connexin-linked injury mechanisms, which include
the expansion of cell death via gap junction channels and the opening of hemichannels that by
themselves may lead to cell injury/death [11–14]. Connexins are membrane proteins that form
gap junctions and hemichannels and play a key role in the development and function of the
female reproductive system (reviewed in [15]). Gap junctions enable the direct and selective
exchange of chemical/metabolic signals between cells [16, 17] but under pathological condi-
tions such as I/R, gap junctions may expand cell death by spreading cell death signals between
neighboring cells [12]. On the other hand, gap junctions may act protectively as well by distrib-
uting and supplying cells with nutrients, metabolites, and survival messengers [18]. Hemichan-
nels open during cellular stress conditions [11, 19] creating a non-selective leakage pore,
through which atomic ions and essential metabolites can escape from the cell leading to cell
damage and cell death [18, 20]. Several studies have demonstrated that blocking connexin
channels, in particular hemichannels may limit I/R injury in isolated cardiomyocytes as well as
the intact heart [21, 22]. Moreover, we previously showed that Gap27, a short sequence identi-
cal to the second extracellular loop of Cx43 protects human blood vessels against cryopreserva-
tion-induced cell death in smooth muscle cells [23].
Here, we investigated whether connexin channel inhibition with Gap27 during the storage
period between donor uterus retrieval and its implantation in the recipient patient, could
improve the uterus condition in terms of cell death scoring. We tested both cold (4˚C) and
warm (37˚C) static storage conditions and also checked whether warm I/R applied to the
uterus in situ while still in the donor, influenced the uterus outcome after storage.
Materials and methods
Patients
Tissue samples were taken from the uteri of healthy transgender patients of Western European
descent undergoing a laparoscopic hysterectomy and ovariectomy. Transgender patients in
the age range of 18–27 years were included. Patients with complex medical history like diabe-
tes, heart and lung disease or thrombo-embolic disease were excluded from the study; no
organs were procured from prisoners. In total, 9 uterus donors were recruited in the study, 4
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in Experiment 1 (recruitment from December 2014 to January 2016) and 5 in Experiment 2
(recruitment from July 2017 until April 2018). The donors were females, in transition; their
mean age was 21.6 years old (median age 22), 7 were still studying and two were working, one
patient was from Holland, and eight from Belgium. The recruitment took place during outpa-
tient clinic visit, transgender patients planning a surgery were asked to participate in this study
after a thorough explanation. The recruitment was done in the Ghent University Hospital and
the research was done in the Department of Basic and Applied Medical Sciences, Ghent
University.
Before the surgery, the patients were hormonally treated for approximately a year with
Nebido1.
Ethical approval
All material from patients was collected after their written informed consent before surgery
according to a protocol that was approved by the ethical committee of the Ghent University
Hospital. All the experiments were carried out in accordance with the protocol approved by
the ethical committee of the Ghent University Hospital.
Experiment 1
In situ warm I/R and uterus biopsy sampling. Uterus biopsies were taken in transgender
patients (N = 4) during laparoscopic hysterectomy and ovariectomy combined with mastec-
tomy. The hysterectomy was performed to near completion except for the ligation and transec-
tion of the uterine arteries and veins. Each of the four patients had five uterine biopsies taken
during the surgery; the first uterine biopsy (UB1), was then taken before bilateral clipping of
the uterine arteries and veins, the second (UB2), 10 min after clipping, corresponding to 10
min of warm ischemia. The third biopsy (UB3) was taken after 1 h of warm ischemia and the
fourth (UB4) just before removing the vessel clips, corresponding to 3 h of warm ischemia.
During these 3 h of in situ warm ischemia, plastic surgeons performed the bilateral mastec-
tomy. Upon finishing the mastectomy, the uterine vessel clips were removed. The last biopsy
(UB5) was taken 10 min after reperfusion; thus, warm I/R involved 3 h of ischemia followed by
10 min of reperfusion. All biopsies during surgery were hysteroscopically guided, taken with a
Spirotome Cervicore device (Cervical Macro Biopsy System, 14 G x 350 nm, Medinvents, Bel-
gium) and had approximately 1.6 mm in diameter. The uterine biopsies were taken from the
fundus of the uterus, along an inside to outside direction (endometrium to myometrium) over
the thickness of the wall. Fig 1B–1D shows the clipping of the uterus and the procedure of tak-
ing biopsies.
Ex-situ biopsy sampling and storage. After the uterus was removed from the patient
(N = 3, samples from one patient were not processed according to our storage protocol due to
peptide solubility problem), it was flushed three times (500 ml) with cooled Custodiol1 perfu-
sion solution (Histidine-Tryptophan-Ketoglutarate, HTK solution, Franz Köhler Chemie
GmbH, Germany) to wash the organ from the blood (see Fig 1E–1G). Custodiol1 is often
used for heart cold storage, which, like the uterus, consists mainly of muscle cells. Storage in
Custodiol1 was suggested to be superior to other solutions [9, 24, 25] but there are currently
no hard data to support such claim. Here, we chose Custodiol1 because of its musculoplegic
properties.
Uterus biopsies (3 biopsies per patient per storage condition) were collected immediately
after that (see Fig 1A ex situ) with a Biopsy Punch (6 mm in diameter, Stiefel, Belgium). Ex-
situ biopsies were kept in small containers filled up with Custodiol1 solution with or without
Gap27 peptide either in the fridge (4˚C) or warm incubator (37˚C), to mimic cold or warm
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Fig 1. Design of Experiment 1. A. The protocol of Experiment 1 (left) and the sequence of the uterine biopsies (right). B-G Pictures illustrating
the uterus during warm ischemia and after hysterectomy. (B) Clipping of the uterine arteries and veins using two surgical clips (black arrows).
UBo, uterine body; Ov, ovary. (C) Uterus during the first (UB1) and second biopsy (UB2) taken at the site indicated by the rectangle. (D)
Intrauterine image during biopsy of UB2. (E) Uterus before flushing with Custodiol1. (F) Uterus after flushing before taking samples for cold/
warm storage. (G) Uterus after flushing, depicting the catheter entry site.
https://doi.org/10.1371/journal.pone.0243663.g001
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storage conditions. After storage, samples were prepared as described under Sample prepara-
tion and TUNEL staining.
Experiment 2
In-situ short warm ischemia, biopsy sampling and cold storage. We investigated cell
death during cold storage of uterus biopsies after in situ exposure to 20 min warm ischemia
(Fig 2) induced by clipping the uterine arteries as was done in Experiment 1. The uterus was
then removed from the patients (N = 5), without reperfusion and was flushed ex-situ three
times with Custodiol1 perfusion solution as was done for the warm I/R condition of Experi-
ment 1. Uterus biopsies (n = 5, one biopsy from 1 patient per storage condition) were only col-
lected after organ retrieval with a Biopsy Punch (6 mm diameter, Stiefel, Belgium) and were
kept in perfusion solution with or without Gap27 peptide and cold-stored at 4˚C for 0 h, 1 h, 5
h, 12 h or 24 h. After storage, biopsy samples were prepared as described under Sample prepa-
ration and TUNEL staining.
Fig 2. Design of Experiment 2. The uterine arteries were clipped in situ for 20 min prior organ retrieval. After the uterus was removed, uterine samples
were collected and stored up to 24 h in cold storage conditions (4˚C) with or without Gap27 peptide.
https://doi.org/10.1371/journal.pone.0243663.g002
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Sample preparation and TUNEL staining
At the end of the storage period, biopsies were fixed in 4% formaldehyde (VWR, Belgium) at
4˚C overnight. After washout, samples were embedded in paraffin and cut into 5 μm sections.
On the day of the staining, slides with tissue samples were deparaffinized and permeabilized
for 8 min in 0.1% TritonX-100 (VWR, Belgium) dissolved in PBS (Sigma-Aldrich, Belgium).
Apoptosis was detected by in situ terminal deoxynucleotidyl transferase (TdT)-mediated deox-
yuridine triphosphate (dUTP) nick end-labeling (TUNEL), using In Situ Cell Death Detection
Kit (Roche, Belgium). Samples were incubated with the TUNEL reaction mixture for 1 h at
37ᵒC in the dark. Samples treated with DNase I (1000 u/ml in H2O, Sigma-Aldrich, Belgium)
for 10 min were used as a positive control and not exposed to TdT enzyme, as a negative con-
trol. Next, samples were washed with PBS and stained with 1 μg/ml DAPI (Life Technologies
Europe) in PBS and were mounted with Vectashield mounting medium (Labconsult, Brussels,
Belgium). Three random slides per replicate and three images across the sample were acquired
with a Nikon TE300 epifluorescence microscope equipped with a 10× objective (Plan APO,
NA 0.45; Nikon), and a Nikon DS-Ri1 camera (Nikon BeLux, Zaventem, Belgium). The num-
ber of TUNEL-positive cells was expressed relative to the total number of nuclei stained with
DAPI. The calculations were performed using FIJI ImageJ after the application of a threshold
corresponding to the upper level of the background signal.
Gap27 peptide treatment
Gap27, a short peptide identical to a sequence on the second extracellular loop of Cx43
(SRPTEKTIFII), was used in this study to block connexin gap junctions and hemichannels
during storage of uterus biopsies. Inhibition of gap junctions by Gap27 is characterized by an
IC50 of 20–30 μM [26] and we used 200 μM to obtain an estimated 87–91% inhibition. The
IC50 for hemichannel inhibition is ~161 μM (Hill coefficient of 2; [21] giving ~61% inhibition
at 200 μM concentration. Previous work demonstrated that 200 μM of Gap27 is indeed suffi-
cient to significantly reduce cell death in human blood vessels after cryopreservation and thaw-
ing [23]. Gap27 was synthesized by Pepnome Limited (Jida Zhuhai, China) at>90% purity.
The peptide was dissolved in the transplantation solution at a final concentration of 200 μM.
Data and statistical analysis
Data are expressed as mean ± SEM, with ‘n’ denoting the number of replicates; ‘N’ indicates
the number of patients. The number of patients from which samples were taken is specified
per experiment. Statistical analysis was performed using GraphPad Prism 7 software (Graph-
Pad Software, San Diego, USA). In Experiment 1, we used one-way ANOVA with Sidak’s mul-
tiple comparisons. For Experiment 2, we used a two-way ANOVA with Sidak’s multiple
comparisons. The level of statistical significance level was set at p< 0.05.
Results
In situ warm ischemia/reperfusion and effect of Gap27 on subsequent cold
or warm storage conditions
The study design was divided into two parts: an in situ and ex situ part, an overview of which
is presented in Fig 1A. In in situ part of Experiment 1, we investigated cell death as estimated
from TUNEL scores in uterus biopsies taken at various time points during 3 h of in situ warm
ischemia (clipping of uterine arteries and veins in the patient) followed by 10 min of reperfu-
sion (release of clips) (Fig 1A and 1B). Based on the results of four patients (N = 4) with one
biopsy sample taken at each time point per patient (n = 4; UB1—UB5), we observed that the
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highest percentage of TUNEL-positivity was in uterus biopsy taken after 1 h of warm ischemia
(UB3), which was significantly above the control value before induction of warm ischemia
(p = 0.04; Fig 3). Surprisingly, 3 h of warm ischemia did not trigger significant TUNEL positiv-
ity (UB4), nor did 10 min of reperfusion (Fig 3). As a result, the significant TUNEL positivity
observed for the UB3 sample appeared transient as the values tended to decrease gradually,
and none of those were significantly above control. The disappearance of TUNEL positivity
indicates that the cellular energy potential is still able to support DNA repair; such recovery
from cell death initiation has been called anastasis [27]. Other publications of reversal of cell
death events after DNA damage were documented before [28, 29]. Overall, our findings sug-
gests a rather low sensitivity of the uterus to warm ischemia and absence of reperfusion injury
after 10 min of restored circulation.
We next tested cell death after 5 h of cold or warm storage. To that purpose, after 3 h of in
situ warm ischemia and 10 min of reperfusion, the uterus was removed, biopsies were taken
and subsequently kept under either cold (4˚C) or warm (37˚C) storage conditions in Custo-
diol1 solution. We used 3 biopsy samples from each of the 3 donor patients included in this
study per storage condition. As observed in Fig 4, TUNEL positive counts after cold storage
(18.6% ± 1.9%) were significantly lower (p = 0.03) of those associated with warm storage
(36.5% ± 10.7%). Additionally, the inclusion of Gap27 (200 μM) in the cold storage solution,
strongly and significantly decreased TUNEL positivity by a factor of 4 (from 18.6 ± 1.9% to
4.35 ± 1.1%; p = 0.004), attaining a value that was in the same order of TUNEL positivity just
before the start of the storage procedure (5.5 ± 2.7%, sample UB5, Fig 3). In contrast, Gap27
had no protective effect at all when applied during conditions of warm storage (Fig 4A and 4B).
In situ warm ischemia and effect of Gap27 on subsequent cold storage
Due to a change in the surgical procedure whereupon the mastectomy was not combined any-
more with a hysterectomy but done as a separate surgical intervention, application of a long 3
Fig 3. Evolution of TUNEL scoring in uterus biopsies before, during, and after uterine vessel clipping. The imposed warm ischemia significantly
increased the number of TUNEL-positive cells, reaching a peak after 1 h of ischemia. After 3 h of ischemia, values decreased and were not different
from control before clipping. Following 10 min of reperfusion, TUNEL scores were in the range of the UB2 values. All data are presented as
mean ± SEM, � p< 0.05, one-way ANOVA with Sidak’s multiple comparisons, n = 4 from 4 patients.
https://doi.org/10.1371/journal.pone.0243663.g003
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h warm ischemia period was not possible for follow up experiments. Therefore, we adapted
the protocol of Experiment 2, and the in situ warm ischemia period was reduced to 20 min.
Given the fact that reperfusion did not provoke significant cell death in Experiment 1, we fur-
ther decided not to apply a reperfusion phase for Experiment 2. Because of the more limited
time available during surgery, we only took uterus biopsies after removal of the uterus from
the body, and its flushing with Custodiol1 solution. We then exposed the samples to various
periods of cold storage (4˚C) up to 24 h, in control, or with Gap27 added to the solution (flow-
chart of Experiment 2 see Fig 2). We included 5 patients and used 1 biopsy per patient per con-
dition (n = 5). The results demonstrated a gradual increase in TUNEL positivity during cold
storage, with only the 12 h and 24 h storage periods attaining statistical significance as com-
pared to the 0 h measurement (p = 0.013 and p< 0.0001 for 12 h and 24 h respectively; Fig 5).
The TUNEL score at 5 h cold storage was significantly lower compared to 5 h cold storage
after the 3 h of warm I/R protocol of Experiment 1 (first bar of Fig 4B) (8.6 ± 1.5% n = 7 vs.
18.6 ± 3.4%; one-tailed t-test p< 0.05), reflecting the shorter in situ warm ischemia period (20
Fig 4. Warm vs. cold storage after long warm I/R and the effect of Gap27. A. Representative TUNEL staining images of uterus tissue in the different
experimental groups. TUNEL-positivity in green and nuclear DAPI staining in blue. B. TUNEL scores after warm storage (37 ˚C, 5 h) were significantly
higher compared to cold storage. The inclusion of Gap27 in the cold storage medium significantly decreased the TUNEL scores. In the warm storage
group, Gap27 had no protective effect. � p< 0.05, �� p< 0.005, one-way ANOVA with Sidak’s multiple comparisons of selected bars, n = 9 from 3
patients.
https://doi.org/10.1371/journal.pone.0243663.g004
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min vs. 3 h) and the absence of in situ reperfusion. Gap27 did not protect as inferred from the
TUNEL scores in the first 12 h period, but it significantly reduced TUNEL positivity after 24 h
of storage by ~35% (control: 25.4 ± 2.4% vs. Gap27: 17.2 ± 1.0%; p = 0.028) (Fig 5).
Discussion
We evaluated how initial warm ischemia, and subsequent different storage conditions, influ-
enced the viability of the human uterus. We found that Gap27 protects the uterus against cell
death, measured by TUNEL staining, during cold storage while it was ineffective against warm
storage. Interestingly, protection by Gap27 was stronger and quicker when the uterus had pre-
viously experienced warm I/R (3 h/10 min) compared to 20 min ischemia without reperfusion,
in which case protection was only detectable after 24 h cold storage.
During ischemia, due to restricted or reduced blood flow, the tissue is deprived of oxygen
and blood nutrients, causing a gradual loss of cellular homeodynamics. At reperfusion, these
changes induce inflammation and oxidative stress that can lead to an organ’s loss of function
[30]. The detrimental effects of warm I/R are well known in solid organ transplantation, and it
is crucial to limit ischemia exposure time [31, 32]. Warm ischemia during transplantation usu-
ally lasts less than 1 h, but in complicated cases, could rise to 2–3 h.
Fig 5. Cold storage after short warm ischemia without reperfusion. Evolution of TUNEL scores during cold storage.
After 12 h and 24 h of cold storage, TUNEL scores were significantly increased. Inclusion of Gap27 during cold storage
significantly decreased the TUNEL score only for the 24 h storage period. �, # p< 0.05, ���� p< 0.0001, two-way
ANOVA to assess the effect of time and Gap27, � is the comparison of time points to 0 h and # shows the comparison
of Gap27 treatment to control, n = 5 from 5 patients.
https://doi.org/10.1371/journal.pone.0243663.g005
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We observed low sensitivity of the uterus to 3 h in situ warm ischemia and the apparent
absence of reperfusion injury following restored circulation in the patient. Adachi et al., 2016
and Kisu et al., 2017 used a similar experimental set-up in non-human primates to investigate
the allowable exposure time to warm ischemia induced by clamping the uterine vessels for up
to 8 h followed by 3 h of reperfusion [33, 34]. In their studies, light and electron microscopy
investigations demonstrated no abnormalities at the organelle level, and menstruation was
restored with warm ischemia times of less than 4 h [33, 34]. Brännström et al. reported warm
ischemia times in humans are tolerable for at least 1 h 30 min [35, 36]. Our observations corre-
spond with the non-human primate studies and demonstrate that the tolerable ischemic time
of human uterus is in the order of 3 h.
Moreover, the in situ warm I/R experiment mimics what the uterus would experience dur-
ing other types of procedures where the uterine artery is temporarily blocked. For example,
transient blocking of the uterine perfusion by clipping uterine arteries is used to prevent exces-
sive blood loss during laparoscopic myomectomy [37]. Studies by Wang et at. 2008 and Liu
et al. 2011 confirm that blocking uterine perfusion for 1.5–2 h does not affect uterus function
[38, 39]. However, in myomectomy surgery, only the uterine artery is clipped while here in
our study, we transected all other accessory uterine vessels before clipping the uterine artery
and vein.
Apoptotic cell death progressed faster after warm than after cold storage. Moreover, cold
storage injury was two-fold higher when the organ was previously exposed to the long in situ
warm I/R compared to brief warm ischemia. This indicates that warm ischemia initially trig-
gered a cellular stress response which evolves to cell death during subsequent storage. When
the organ was retrieved within 20 min, cell death significantly increased only after 12 h of cold
storage, which confirms the observations made by Wranning et al. who found an allowable
cold storage time of at least 6 h for human uterine smooth muscle tissues in protective solution
[9]. Some studies in humans claim that the uterus may be resistant to cold storage for up to 12
h without histological changes [40] or even 24 h based on electron microscopic evaluation
[41]. Recently, a case study of the first baby born from a multi-organ deceased donor was pub-
lished. The total ischemia time was 7 h 50 min, with 6 h 20 min of cold and 1 h 30 min of
warm ischemia [8]. However, the study did not specify the cold storage time. Hence, the allow-
able ischemia times require further scrutiny. Altogether, our results confirm that cold storage
is superior to warm storage, and the uterus can withstand cold storage for a longer time.
It has been confirmed that gap junctions play a role in the pathogenesis of ischemia, cold
storage, and reperfusion injury in mice [42, 43]. The insult caused by oxidative stress in the
regions of disturbed blood flow might be propagated by gap junction channels as cell death
signaling molecules spread to neighboring cells by the bystander effect, causing cells or tissue
damage amplification and deterioration [44]. Apart from gap junctions, the opening of
unpaired hemichannels may also be involved in cell injury (reviewed in [45]), as exemplified
by the protective effects of Gap26 and Gap27 in reducing ischemic cell injury in the brain and
myocardial I/R in the intact heart [22, 46, 47].
Here, Gap27 strongly protects the uterus against cell death during cold storage when surgery
involved pre-exposure to long warm I/R. Thus, Gap27 protection seems to depend on the pre-
ceding in situ warm ischemia, indicating that the peptide protects against cell death processes
that were initiated when the uterus was still in the patient rather than by storage-induced pro-
cesses. Cell death processes initiated during long, in situ warm ischemia, continue during the
warm storage. In this case, cell death probably overwhelms the protective potential of Gap27,
possibly because other, non-connexin signaling pathways are activated. Collectively, this indi-
cates that the peptide does not primarily target intrinsic storage-linked processes but rather
events initiated in the preceding period of uterus retrieval from the donor.
PLOS ONE Gap27 protects human uterus against cell death during cold storage
PLOS ONE | https://doi.org/10.1371/journal.pone.0243663 December 10, 2020 10 / 14
There are several limitations to our study. First, the experimental warm ischemia only rep-
resents the first phase during organ retrieval but lacks a second warm ischemia phase that
would occur during re-anastomosis upon organ implantation. Second, we did not evaluate the
endometrium separately since before surgery, patients went through long hormonal treatment
and the endometrial layer was thin and non-active. Third, the number of available patients was
low and statistical power suboptimal, making it possible that the results obtained do not neces-
sarily apply to a larger patient cohort, therefore, the results should be interpreted with caution.
Lastly, we could not distinguish between apoptotic vs. necrotic cell death because the readout
was based exclusively on TUNEL staining. Caspase-3 staining was tested, but statistical vari-
ability was large, precluding the extraction of accurate data. Further studies evaluating addi-
tional readouts are necessary, including uterus morphology, oxidative stress markers and
cellular, biochemical or proteomic markers of distinct cell death modes such as necrosis, apo-
ptosis, necroptosis, ferroptosis, autophagic cell death, cellular energy catastrophe and others.
In conclusion, the setting of our I/R experiment is unique because it is performed inside the
human body. It mimics conditions where the uterus would be removed from a deceased donor
after experiencing long warm ischemia because of its delayed retrieval after removal of life-sav-
ing organs. Long warm in situ I/R appears to be well tolerated by the human uterus. However,
it triggers significant cell death that becomes apparent during storage. Inclusion of Gap27 dur-
ing cold storage could be useful to protect the uterus obtained from deceased donors where
marked warm ischemia is likely because priority retrieval of life-saving organs. This study is a
promising lead to the discovery of new measures for uterus protection during the long period
between organ retrieval and re-implantation, which may promote implantation success.
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